PLASMA FENFLURAMINE LEVELS, WEIGHT-LOSS, AND SIDE-EFFECTS

被引：39

作者：

INNES, JA

WATSON, ML

FORD, MJ

MUNRO, JF

STODDART, ME

CAMPBELL, DB

机构：

[1] EASTERN GEN HOSP,EDINBURGH,SCOTLAND

[2] SERVIER RES INST,GREENFORD,MIDDLESEX,ENGLAND

来源：

BRITISH MEDICAL JOURNAL | 1977年 / 2卷 / 6098期

关键词：

D O I：

10.1136/bmj.2.6098.1322

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1322 / 1325

页数：4

共 29 条

[1]

BALLASSE EO, 1972, VIE MEDICALE CANADA, P44

[2]

BLUNDELL JE, 1977, INT J OBESITY, V1, P15

[3] BIPHASIC ACTION OF A 5-HYDROXYTRYPTAMINE INHIBITOR ON FENFLURAMINE-INDUCED ANOREXIA [J].

BLUNDELL, JE ;

LATHAM, CJ ;

LESHEM, MB .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (06) :492-494

[4] GAS CHROMATOGRAPHIC MEASUREMENT OF LEVELS OF FENFLURAMINE AND NORFENFLURAMINE IN HUMAN PLASMA, RED CELLS AND URINE FOLLOWING THERAPEUTIC DOSES [J].

CAMPBELL, DB .

JOURNAL OF CHROMATOGRAPHY, 1970, 49 (03) :442-&

[5]

CAMPBELL DB, 1973, VIE MEDICALE CANADA, V2, P43

[6]

DATEY KK, 1973, BRIT J CLINICAL PRAC, V17, P373

[7]

DIEM K, 1972, DOCUMENTA GEIGY

[8]

Follows O J, 1971, Br J Clin Pract, V25, P236

[9]

FUXE K, 1975, POSTGRADUATE MEDI S1, V51, P31

[10]

GARATTINI S, 1975, POSTGRADUATE MEDI S1, V51, P23

← 1 2 3 →